In the first paper of this series (1) The meningococcic agglutinin content of 252
In the first paper of this series (1) a technic was described which affords a simple method of detecting type specific agglutinins in individuals suffering from meningococcic infection. Agglutinin titers over Moo were regarded as significant of the presence of specific antibody, while those up to and including Moo were considered within the normal range. If this test was to have practical application for diagnostic purposes, or for determining the type of the infecting organism in cases where meningococci were not cultured, it seemed essential to study the agglutinin titers in bacteriologically proved cases of meningococcic infection during the entire course of the disease to determine: (a) When are agglutinins found in diagnostically significant titers? (b) What types of agglutinins are found? (c) Do these correspond in prevalence with the type distribution of recently isolated strains? (d) Do the types of agglutinins in patients' serums correspond in type and valence with the infecting organism in cases where both the infecting organism and the patient's serum were available for study ? The meningococcic agglutinin content of 252 bacteriologically proved cases of meningococcic infection was studied from March, 1942 to March, 1945 . Samples of serum were obtained from the same patient from 1 to 34 times at intervals of from 1 to 21 days, i.e., during the acute, subacute, and convalescent phases of the disease. All the patients included in this study received one of the sulfonamide drugs and none received serum.
METHOD
The method used was that described in our previous paper (1) . Briefly, all serums were tested for Group I, Group II and Group II-alpha agglutinins. The increased twofold. The tests were incubated at 370 C. for 2 hours, centrifuged at high speed for 10 minutes and kept in the refrigerator overnight. Readings were made after centrifugation and also following overnight storage. The last tube showing definite (2 plus) clumping was considered indicative of the titer of the serum.
RESULTS
Agglutinins in significant titers were found, for 1 or more of the types of meningococci, in 188 of 252 (75 per cent) cases. Only 1 sample of blood was obtained in each of 149 cases, 2 samples were collected in each of 59 instances, and from 3 to 34 samples were taken from each of 47 patients. For purposes of analysis, the 506 samples of serum obtained from these patients were arbitrarily grouped according to the phase of illness during which they were obtained. All samples of serum collected from the first to the fifth day after the onset of the disease were considered as representative of the acute stage, those from the sixth to the tenth day as subacute stage, and those from the eleventh These results indicate that there is a correlation between the infecting organism and the antibodies produced in the patient's serum.
DISCUSSION
The significance of finding type specific meningococcic agglutinins in human serums in the past was obscured by the antibodies introduced, in the majority of cases, when therapeutic antiserum was used. The use of chemotherapy alone, however, has made it possible to study the antibodies produced by the infecting organism itself.
The results of this study show that the type specific agglutinin production in cases of bacteriologically proved meningococcic infection followed the classical curve of other febrile diseases. The titers varied from /200 to 'A600. Agglutinins were observed more regularly during the subacute than during the acute phase and reached their maximum titers during the early part of the convales- A group of workers (10) recently reported essentially similar results in a group of 47 bacteriologically proved cases of meningococcic infection, although they obtained a lower range of agglutinin titers. It should be noted that these investigators used freshly-isolated strains and a slightly different technic for their agglutination test. In our original paper (1), we compared several methods of incubation, which included a centrifugation method similar to the one employed by Dowling and his collaborators. We pointed out in that report that immediate centrifugation did not appreciably alter the titer of the serum.
The usefulness and the limitations of this test as a diagnostic procedure are those of all other serologic tests. In the absence of clinical evidence, it is not possible to distinguish between active and latent infection. We showed (1) that agglutinins in significant titers were found in healthy hospital and laboratory personnel in repeated contact with the infection. In these instances, no attempt was made to correlate these findings with the carrier state. However, in 1935, one worker (11) was able to demonstrate agglutinins in the serums of carriers and felt that this cordition could be looked on as an infection. In this connection we should like to mention also the finding of an apparent source of false positives in a group of 11 of 46 instances of gonococcic infection. The significance of this observation merits further study.
SUMMARY AND CONCLUSIONS 1. Agglutinins were found in diagnostically significant titers in the serums of bacteriologically proved cases of meningococcic infection during the acute, subacute, and convalescent phases.
2. There was considerable variation in individual cases both as to the time at which the agglutinins first appeared in significant titers and their persistence in the patient's serum. Titers fell to pre-infection levels between the third week and fourth month after onset.
3. Agglutinins were found for Group I, Group II, and Group II-alpha meningococci alone and in combination with each other.
4. The agglutinins corresponded in prevalence with the trpe distribution of the infecting organisms. 
